Key statistics
On Friday, Harrow Inc (HROW:NMQ) closed at 35.89, 72.13% above the 52 week low of 20.85 set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 36.40 |
---|---|
High | 36.93 |
Low | 35.60 |
Bid | 35.60 |
Offer | 37.59 |
Previous close | 36.14 |
Average volume | 494.06k |
---|---|
Shares outstanding | 36.70m |
Free float | 30.59m |
P/E (TTM) | -- |
Market cap | 1.33bn USD |
EPS (TTM) | -0.607 USD |
Data delayed at least 15 minutes, as of Jul 18 2025 21:00 BST.
More ▼
- Samsung Bioepis Enters into a Partnership with Harrow for Commercialization of Ophthalmology Biosimilars Portfolio in the United States
- Harrow Enters into Commercialization Agreement with Samsung Bioepis for Ophthalmology Biosimilars Portfolio in the United States
- Harrow Appoints Mike Biega as Vice President of Investor Relations and Communications
- Harrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa Pharmaceuticals
- Harrow to Present at Two Investor Conferences in May
- Harrow Announces First-Quarter 2025 Financial Results
- Harrow to Report First Quarter 2025 Financial Results After Market Close on May 8, 2025
More ▼